Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology
-
Zhongguo Shi Yan Xue Ye Xue Za Zhi · Dec 2011
Review[Advancement of peptide vaccines for hematologic malignancies].
Despite recent significant advances in the treatment of hematological malignancies, relapse of this disease is of great note with the existence of the minimal residual disease (MRD). Tumour peptide vaccine seems to be one of the effective immunotherapies for eliminating tumor cells of MRD. This review focuses on the late results of clinical trails of peptide vaccination protocols targeting WT1, RHAMM, BCR-ABL, PR1 in hematological malignancies and the development of specific immune responses to PRAME and Survivin peptides. An outlook to heteroclitic peptides, new adjuvants, combined peptide vaccines and Ad-tWT1 vaccine is also given to further explore the possibility to enhance the efficacy of the peptide vaccine.
-
Zhongguo Shi Yan Xue Ye Xue Za Zhi · Aug 2009
Review[Acute renal failure after hematopoietic stem cell transplantation-review].
Hematopoietic stem cell transplantation is a common procedure for the treatment of hematologic malignancies and some non-malignant hematologic disorders. In addition to other transplant-related organ toxicities, acute renal failure is a common complication following allogeneic hematopoietic stem cell transplantation. This review discusses the incidence, etiology, risk factors, and prognosis of renal failure associated with three commonly used transplantation models: myeloablative autologous, myeloablative allogeneic, and non-myeloablative allogeneic hematopoietic stem cell transplantations.